Pharmaceutical Industry Reports

For drugmakers, the golden era of the 1990s and early part of the last decade, when they seemed to effortlessly churn out new multibillion-dollar pills for the masses along with double-digit quarterly profit increases, is not even in the rearview mirror any more.

Twenty-two percent of healthcare IT and pharma mergers and acquisitions in 2011 were financed by private equity, venture capital and other investment firms, according to a new report from investment bank Berkery Noyes.

In a strange twist of events, the proposed Clinical Drug Act will not be supervised by the Ministry of Health, but instead by the Ministry of Finance, professionals in the health sector claim.

The packaging machines, which MULTIVAC will be presenting in Stuttgart, fulfill the high requirements of the medical products industry. The solutions ensure a secure, reproducible and traceable packaging process. At the same time they offer a high degree of individualisation of the package contents and its product coding.

The year 2012 sets the stage for an exciting, yet challenging time for the pharmaceutical industry. To address what lies ahead in the New Year, the pharma industry's leading experts all plan to be at the Pharma Market Research Conference.